Wilson A P, Shrimpton S, Jaderberg M
Department of Clinical Microbiology, University College Hospital, London, UK.
J Hosp Infect. 1992 Nov;22 Suppl A:9-21. doi: 10.1016/s0195-6701(05)80003-9.
The efficacy of amoxycillin-clavulanic acid as antibiotic prophylaxis in surgery has been assessed in numerous clinical studies, chiefly in abdominal and gynaecological surgery. A meta-analysis of 21 trials covering 2685 patients given amoxycillin-clavulanic acid and 2220 patients given comparator regimens is presented. Monotherapy with amoxycillin-clavulanic acid was as effective as the comparators, including combination regimens utilizing gentamicin or metronidazole, in preventing wound infections (median wound infection rates were 6% and 10% respectively). The antibacterial activity of amoxycillin-clavulanic acid covers the broad range of aerobic Gram-negative and anaerobic organisms that have a major role in postoperative infections. In addition, amoxycillin-clavulanic acid may have benefits in terms of convenience, tolerance and cost.
阿莫西林-克拉维酸作为手术抗生素预防用药的疗效已在众多临床研究中得到评估,主要是在腹部和妇科手术中。本文对21项试验进行了荟萃分析,涉及2685例接受阿莫西林-克拉维酸治疗的患者和2220例接受对照方案治疗的患者。在预防伤口感染方面,阿莫西林-克拉维酸单药治疗与对照药物(包括使用庆大霉素或甲硝唑的联合方案)效果相当(伤口感染率中位数分别为6%和10%)。阿莫西林-克拉维酸的抗菌活性涵盖了在术后感染中起主要作用的广泛需氧革兰氏阴性菌和厌氧菌。此外,阿莫西林-克拉维酸在便利性、耐受性和成本方面可能具有优势。